Manchester Financial’s Zomedica Corp. ZOM Stock Holding History

Manchester Financial’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,300	Closed	-$3K	–	115
2022 Q2	$3K	Hold	12,300	–	–	﹤0.01%	105
2022 Q1	$4K	Hold	12,300	–	–	﹤0.01%	105
2021 Q4	$4K	Sell	12,300 -11,900	-49%	-$5.36K	﹤0.01%	94
2021 Q3	$13K	Hold	24,200	–	–	0.01%	86
2021 Q2	$20K	Hold	24,200	–	–	0.01%	82
2021 Q1	$38K	Buy	24,200 +400	+2%	+$654	0.02%	213
2020 Q4	$5K	Buy	+23,800	New	+$3.04K	﹤0.01%	468

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PWMG

Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Manchester Financial's ZOM Position: Q3 2022 in Review

Manchester Financial sold out of Zomedica Corp. (ZOM) in Q3 2022, closing a stake of 12,300 shares — an estimated $3K sold.

Manchester Financial first reported a position in ZOM in Q4 2020 and held it in 7 quarters. The position peaked at $38K in Q1 2021. 87 funds tracked by Wall St. Rank hold ZOM as of Q3 2022.

Manchester Financial reported no remaining Zomedica Corp. position as of Q3 2022 after selling out during the quarter.
Manchester Financial sold 12,300 Zomedica Corp. shares in Q3 2022, an estimated $3K.
Manchester Financial first reported a position in Zomedica Corp. in Q4 2020 and held it in 7 quarters.
Manchester Financial's Zomedica Corp. position peaked at $38K in Q1 2021.
87 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2022.

Based on Manchester Financial's 13F filing for Q3 2022, filed 14 Nov 2022.